No Picture
News

STAT+: Pharmalittle: Patient groups to pressure Medicare over Alzheimer’s drug; pharma says it’s duty-bound to sell meds in Russia

Patient groups are mounting a pressure campaign aimed at persuading the U.S. government to loosen proposed restrictions on new Alzheimer’s treatments. Click here to view original post… […]

No Picture
News

STAT+: Pharmalittle: Pfizer sales forecasts for Covid shot and pill fall short; letter-writing campaigns target CMS over Alzheimer’s drug

Biosplice, once the world’s most valuable biotech startup, is laying off nearly a quarter of its workforce and has stopped internal development of a hair-loss treatment. Click here to view original post… […]

No Picture
News

STAT+: Pharmalittle: Alzheimer’s patient groups to protest Medicare plan for Biogen drug; cancer combo treatments are questioned

Alzheimer’s patient groups are planning publicity and lobbying campaigns to protest a Medicare coverage proposal they say could delay the use of new drugs for 10 years. Click here to view original post… […]

No Picture
News

STAT+: Pharmalittle: Lilly and Roche are also losers in the Medicare Alzheimer’s decision; former CRO owner pleads guilty to falsifying data

Medicare may have released a plan to restrict access to the controversial Biogen Alzheimer’s drug, but the biggest losers may be other drug makers readying treatments. Click here to view original post… […]